PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in PMV Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −5 vs. Q1 2024
- Shares held
- 40.5M
- −2.25M (−5.3%) vs. Q1 2024
- Total value
- $65.6M
- −$7.10M (−9.8%) vs. Q1 2024
- New holders
- 21
- 26 more added
- Sold out
- 26
- 31 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −50,500−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −15,492−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −26,182−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −20,217−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −14,491−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −14,180−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −14,020−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −11,419−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −11,315−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,336−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −4,124−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,772−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −3,468−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −1,616−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,279−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −676−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −299−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |